泰达生物更新2026年8月股份变动月报表,股本维持稳定

公告速递
Sep 02

2026年9月2日,天津泰达生物医学工程股份有限公司(以下简称“泰达生物”,股票代码:08189)发布截至2026年8月31日的股份变动月报表。公告显示,该公司在本月未进行新增发行、购回或注销等活动,股本结构保持不变。

根据公告,普通股方面,截至8月底,泰达生物H股数量为1,436,400,000股,内资股数量为697,500,000股,注册股本合计213,390,000元人民币,与上月底相比无变化。公司在报告期内未发生可换股债券、股票期权或其他股权激励计划的授予及行权等变动活动。

公告同时显示,公司已确认满足香港联交所相关上市规则及法律法规的要求。关于本次月报表,由董事孙莉签署。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10